Argent BioPharma Limited

RGT.L · LSE
Analyze with AI
6/30/2024
12/31/2023
6/30/2023
12/31/2022
Assets
Cash & Equivalents£703£3,466£240£638
Short-Term Investments£0£0£0£0
Receivables£477£284£531£646
Inventory£875£657£1,363£955
Other Curr. Assets£0£0£0£0
Total Curr. Assets£2,740£5,010£2,531£2,557
Property Plant & Equip (Net)£6,720£3,559£7,453£5,197
Goodwill£0£0£0£0
Intangibles£0£0£0£0
Long-Term Investments£1,327£699£0£829
Tax Assets£0£0£0£0
Other NC Assets£0£0£0£0
Total NC Assets£8,047£4,258£7,453£6,027
Other Assets£0£0£0£0
Total Assets£10,787£9,267£9,984£8,584
Liabilities
Payables£957£1,322£2,186£1,646
Short-Term Debt£0£4,908£0£4,271
Tax Payable£0£0£0£0
Deferred Revenue£554£0£658£0
Other Curr. Liab.£8,680£322£9,180£490
Total Curr. Liab.£12,176£6,635£13,332£6,526
LT Debt£0£0£0£0
Deferred Rev, NC£3,598£0£4,278£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£17£2,106£21£2,427
Total NC Liab.£4,436£2,274£4,683£3,684
Other Liabilities£0£0£0£0
Cap. Leases£1,045£250£575£1,377
Total Liabilities£16,612£8,908£18,015£10,211
Equity
Pref Stock£0£0£0£0
Common Stock£123,289£63,541£103,691£56,231
Retained Earnings-£129,668-£67,496-£119,169-£61,512
AOCI£648£4,680£8,075£4,022
Other Equity£580£0£0£0
Total Equity-£5,152£725-£7,403-£1,258
Supplemental Information
Minority Interest-£672-£366-£629-£368
Total Liab. & Tot. Equity£10,787£9,267£9,984£8,584
Net Debt-£703£1,442-£240£3,632